Spdr Sp Pharmaceuticals Etf Odds of Future Etf Price Finishing Over 42.98
| XPH Etf | USD 39.52 0.43 1.10% |
Closest to current price SPDR long CALL Option Payoff at Expiration
SPDR |
SPDR SP Target Price Odds to finish over 42.98
The tendency of SPDR Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 42.98 or more in 90 days |
| 39.52 | 90 days | 42.98 | about 38.19 |
Based on a normal probability distribution, the odds of SPDR SP to move over $ 42.98 or more in 90 days from now is about 38.19 (This SPDR SP Pharmaceuticals probability density function shows the probability of SPDR Etf to fall within a particular range of prices over 90 days) . Probability of SPDR SP Pharmaceuticals price to stay between its current price of $ 39.52 and $ 42.98 at the end of the 90-day period is about 58.38 .
Considering the 90-day investment horizon SPDR SP Pharmaceuticals has a beta of -0.0038. This entails as returns on the benchmark increase, returns on holding SPDR SP are expected to decrease at a much lower rate. During a bear market, however, SPDR SP Pharmaceuticals is likely to outperform the market. Additionally SPDR SP Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. SPDR SP Price Density |
| Price |
Predictive Modules for SPDR SP
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SPDR SP Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SPDR SP's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
SPDR SP Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. SPDR SP is not an exception. The market had few large corrections towards the SPDR SP's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold SPDR SP Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of SPDR SP within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.11 | |
β | Beta against NYSE Composite | -0.0038 | |
σ | Overall volatility | 1.63 | |
Ir | Information ratio | -0.16 |
SPDR SP Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of SPDR SP for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for SPDR SP Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| SPDR SP generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Trend Tracker for - Stock Traders Daily | |
| SPDR SP Pharmaceuticals generated-7.0 ten year return of -7.0% | |
| This fund keeps 99.9% of its net assets in stocks |
SPDR SP Technical Analysis
SPDR SP's future price can be derived by breaking down and analyzing its technical indicators over time. SPDR Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of SPDR SP Pharmaceuticals. In general, you should focus on analyzing SPDR Etf price patterns and their correlations with different microeconomic environments and drivers.
SPDR SP Predictive Forecast Models
SPDR SP's time-series forecasting models is one of many SPDR SP's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary SPDR SP's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.
Things to note about SPDR SP Pharmaceuticals
Checking the ongoing alerts about SPDR SP for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for SPDR SP Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| SPDR SP generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Trend Tracker for - Stock Traders Daily | |
| SPDR SP Pharmaceuticals generated-7.0 ten year return of -7.0% | |
| This fund keeps 99.9% of its net assets in stocks |
Check out SPDR SP Backtesting, Portfolio Optimization, SPDR SP Correlation, SPDR SP Hype Analysis, SPDR SP Volatility, SPDR SP History as well as SPDR SP Performance. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
The market value of SPDR SP Pharmaceuticals is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.